Breaking News, Collaborations & Alliances

Aldevron, Acuitas Partner to Expand Capabilities in mRNA LNP Encapsulation

Collaboration increases Aldevron’s services and capabilities as an mRNA sequence-to-vial custom manufacturer.

Author Image

By: Charlie Sternberg

Associate Editor

Aldevron, a global manufacturer of DNA, RNA, and proteins used in cell and gene therapies and vaccine development, has entered a strategic partnership with Acuitas Therapeutics, Inc., a private biotechnology company specializing in the development of delivery systems for nucleic acid therapeutics based on lipid nanoparticles (LNPs).   This partnership will allow Aldevron to expand its capabilities in mRNA LNP encapsulation by incorporating Acuitas’ proprietary LNP encapsulation platform, incre...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters